|
Related Practices
Related Industries
|
Life Sciences Initiative Offers Biotech Industry $250 million in Tax BenefitsJoseph X. Donovan, Jonathan B. Dubitzky, William E. Halmkin, Richard L. Jones, David J. McLaughlin, Walter Nagel, David J. Nagle, Jill Tenley Oldak, Sarah D. WellingsAugust 13, 2008 This client advisory explains the tax provisions of the recently-enacted Massachusetts life sciences initiative. View Client Advisory (PDF)
|
